New shot aims to quiet stubborn seasonal allergies
NCT ID NCT07291284
First seen Jan 11, 2026 · Last updated May 05, 2026 · Updated 18 times
Summary
This study tests an injection called LP-003 in 546 adults with moderate to severe seasonal allergic rhinitis (hay fever) that standard treatments don't control well. Participants receive either the drug or a placebo, and researchers track how much their nasal symptoms (like sneezing, itching, and stuffiness) improve during peak pollen season. The goal is to see if LP-003 can safely ease allergy symptoms better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Shijitan Hospital, Capital Medical University (the formerly Beijing Railway General Hospital)
Beijing, China
Conditions
Explore the condition pages connected to this study.